Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve 1. The audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025.\r\n\r\n2. Recommendation of Final Dividend, if any, for the Financial Year ended March 31, 2025.